Enterprise Trust & Investment’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.87M Sell
31,500
-2,925
-8% -$259K 1.2% 23
2022
Q1
$2.83M Sell
34,425
-1,300
-4% -$102K 1.01% 28
2021
Q4
$2.74M Hold
35,725
0.96% 29
2021
Q3
$2.68M Hold
35,725
1.09% 27
2021
Q2
$2.78M Sell
35,725
-1,820
-5% -$135K 1.14% 26
2021
Q1
$2.76M Sell
37,545
-263
-0.7% -$19.4K 1.24% 27
2020
Q4
$3M Sell
37,808
-131
-0.3% -$10K 1.41% 19
2020
Q3
$3M Sell
37,939
-1,362
-3% -$107K 1.68% 15
2020
Q2
$2.9M Sell
39,301
-210
-0.5% -$15.8K 1.73% 16
2020
Q1
$2.9M Sell
39,511
-2,430
-6% -$191K 2.03% 14
2019
Q4
$3.64M Sell
41,941
-52
-0.1% -$4.27K 2.03% 15
2019
Q3
$3.37M Sell
41,993
-2,600
-6% -$208K 2.07% 14
2019
Q2
$3.57M Buy
+44,593
New +$3.41M 2.22% 12

Other funds holding MRK

Enterprise Trust & Investment's MRK Position: Q2 2022 in Review

Enterprise Trust & Investment reduced its Merck (MRK) stake by 8.5% in Q2 2022, selling an estimated $259K and leaving 31,500 shares worth $2.87M. The position accounts for 1.2% of the portfolio, ranked #23.

Enterprise Trust & Investment first reported a position in MRK in Q2 2019 and has held it in 13 quarters since. The position peaked at $3.64M in Q4 2019. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Enterprise Trust & Investment held 31,500 shares of Merck worth $2.87M as of Q2 2022.
  • Enterprise Trust & Investment sold 2,925 Merck shares in Q2 2022, an estimated $259K.
  • Merck made up 1.2% of Enterprise Trust & Investment's portfolio in Q2 2022, its #23 holding.
  • Enterprise Trust & Investment first reported a position in Merck in Q2 2019 and has held it in 13 quarters since.
  • Enterprise Trust & Investment's Merck position peaked at $3.64M in Q4 2019.
  • 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.